ArticleNature communications2026
Neutral chiral bidentate tellurium-triazoles for enantioselective non-covalent chalcogen-bonding catalysis.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chalcogen-bonding (ChB) has recently garnered significant interest in the field of non-covalent catalysis, providing new possibilities through σ-hole interactions. However, the advancement of the field in enantioselective catalysis relying purely on ChB has been impeded by the inherent directionality of the interaction and presence of several σ-holes on the chalcogen atom, being particularly challenging with neutral ChB-donors. Herein, we report the design and application of chiral ChB-donors able to accomplish the still challenging asymmetric chalcogen-bonding catalysis with neutral ChB systems, reaching enantioselectivities of up to 11:89 e.r. in the anion-binding benchmark Reissert-type reaction of (iso)quinolines. Optimization of the chiral central backbone in rather simple bistriazole-bistelluride-based structures to accomplish a bidentate binding to Lewis basic substrates is performed, leading to the identification of the (R,R)-1,3-diamino cyclohexane moiety as appropriate chiral spacer. While no binding is observed for other chiral central backbones, a moderate affinity to chloride anion as model substrate is recorded for the optimized neutral ChB-donor, for which key binding features are further revealed upon computational analysis on the corresponding catalyst-chloride complex.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.